Hailey Marie Harris, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fetal Membranes, Premature Rupture | 1 | 2021 | 137 | 0.180 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2023 | 1640 | 0.180 |
Why?
|
Body Surface Area | 1 | 2020 | 197 | 0.170 |
Why?
|
Gynecology | 1 | 2023 | 528 | 0.140 |
Why?
|
Clinical Clerkship | 1 | 2023 | 564 | 0.140 |
Why?
|
Obstetrics | 1 | 2023 | 668 | 0.130 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2020 | 1241 | 0.120 |
Why?
|
Benzamides | 1 | 2020 | 1371 | 0.120 |
Why?
|
Pyrazines | 1 | 2020 | 1202 | 0.120 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 1504 | 0.110 |
Why?
|
Students, Medical | 1 | 2023 | 1940 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1923 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2021 | 1869 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3594 | 0.080 |
Why?
|
Pregnancy Complications | 1 | 2021 | 2949 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5662 | 0.070 |
Why?
|
Sepsis | 1 | 2021 | 2585 | 0.070 |
Why?
|
Drug Dosage Calculations | 1 | 2020 | 117 | 0.040 |
Why?
|
Enzyme Induction | 1 | 2020 | 452 | 0.040 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2023 | 495 | 0.040 |
Why?
|
RNA, Neoplasm | 1 | 2020 | 748 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13632 | 0.040 |
Why?
|
Workload | 1 | 2023 | 845 | 0.040 |
Why?
|
Heart Failure | 1 | 2020 | 11701 | 0.030 |
Why?
|
Hematologic Diseases | 1 | 2020 | 496 | 0.030 |
Why?
|
Educational Measurement | 1 | 2023 | 1250 | 0.030 |
Why?
|
Gestational Age | 1 | 2021 | 3580 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4851 | 0.020 |
Why?
|
Headache | 1 | 2020 | 1255 | 0.020 |
Why?
|
Pyrimidines | 1 | 2023 | 3027 | 0.020 |
Why?
|
Cause of Death | 1 | 2020 | 3688 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2023 | 5300 | 0.020 |
Why?
|
Clinical Competence | 1 | 2023 | 4788 | 0.020 |
Why?
|
Stroke Volume | 1 | 2020 | 5521 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12474 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2020 | 12747 | 0.020 |
Why?
|
Pain | 1 | 2020 | 5072 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2021 | 22174 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2023 | 80674 | 0.010 |
Why?
|
Female | 4 | 2023 | 392544 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 26199 | 0.010 |
Why?
|
Humans | 5 | 2023 | 761208 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 29893 | 0.010 |
Why?
|
Male | 3 | 2023 | 360693 | 0.010 |
Why?
|
Middle Aged | 2 | 2020 | 220853 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 58952 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 74239 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 64681 | 0.010 |
Why?
|
Aged | 1 | 2020 | 169288 | 0.000 |
Why?
|